FDA Recall of Olympus Endoscope Reprocessor OER-Pro
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA has announced a recall of 3,354 units of the Olympus Endoscope Reprocessor OER-Pro due to incompatibility issues with certain reprocessing components.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
The Olympus Endoscope Reprocessor OER-Pro is being recalled because the MAJ-1443 and MAJ-1444 components are no longer compatible with it and the OER-Elite automated endoscope reprocessors.
Which Products Are Affected
The affected product is the Olympus Endoscope Reprocessor OER-Pro with Model Number: N3058140. It includes UDI-DI: 04953170258589 and Catalog Number: N3058140. All Lot/Serial Numbers are included, with a total of 3,354 units distributed nationwide in the United States.
What You Should Do
Consumers should follow the instructions in the initial firm notification letter from Olympus Corporation of the Americas for further guidance on this voluntary recall.
Why This Matters
This recall involves medical devices used in healthcare settings, which could affect patient safety due to potential incompatibility issues.
Source
Attribution: FDA. For more information, visit the FDA website and search for Recall Number Z-1613-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (972 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 8, 2026.
Frequently Asked Questions
Common questions about this FDA recall.